Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 1
2012 1
2014 1
2015 1
2017 1
2020 1
2022 6
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Neutralizing antibodies to Omicron after the fourth SARS-CoV-2 mRNA vaccine dose in immunocompromised patients highlight the need of additional boosters.
Rescigno M, Agrati C, Salvarani C, Giannarelli D, Costantini M, Mantovani A, Massafra R, Zinzani PL, Morrone A, Notari S, Matusali G, Pinter GL, Uccelli A, Ciliberto G, Baldanti F, Locatelli F, Silvestris N, Sinno V, Turola E, Lupo-Stanghellini MT, Apolone G; VAX4FRAIL study Group. Rescigno M, et al. Front Immunol. 2023 Jan 27;14:1104124. doi: 10.3389/fimmu.2023.1104124. eCollection 2023. Front Immunol. 2023. PMID: 36776853 Free PMC article.
Humoral and T-Cell Immune Response After 3 Doses of Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Fragile Patients: The Italian VAX4FRAIL Study.
Corradini P, Agrati C, Apolone G, Mantovani A, Giannarelli D, Marasco V, Bordoni V, Sacchi A, Matusali G, Salvarani C, Zinzani PL, Mantegazza R, Tagliavini F, Lupo-Stanghellini MT, Ciceri F, Damian S, Uccelli A, Fenoglio D, Silvestris N, Baldanti F, Piaggio G, Ciliberto G, Morrone A, Locatelli F, Sinno V, Rescigno M, Costantini M; VAX4FRAIL Study Group. Corradini P, et al. Clin Infect Dis. 2023 Feb 8;76(3):e426-e438. doi: 10.1093/cid/ciac404. Clin Infect Dis. 2023. PMID: 35607769 Free PMC article.
mRNA COVID-19 vaccine booster fosters B- and T-cell responses in immunocompromised patients.
Azzolini E, Pozzi C, Germagnoli L, Oresta B, Carriglio N, Calleri M, Selmi C, De Santis M, Finazzi S, Carlo-Stella C, Bertuzzi A, Motta F, Ceribelli A, Mantovani A, Bonelli F, Rescigno M. Azzolini E, et al. Among authors: germagnoli l. Life Sci Alliance. 2022 Feb 15;5(6):e202201381. doi: 10.26508/lsa.202201381. Print 2022 Jun. Life Sci Alliance. 2022. PMID: 35169017 Free PMC article.
Implementing Pre-Therapeutic UGT1A1 Genotyping in Clinical Practice: A Real-Life Study.
Personeni N, Giordano L, Michelini A, D'Alessio A, Cammarota A, Bozzarelli S, Pressiani T, Prete MG, Sandri MT, Stioui S, Germagnoli L, Santoro A, Rimassa L, Mineri R. Personeni N, et al. Among authors: germagnoli l. J Pers Med. 2022 Feb 2;12(2):204. doi: 10.3390/jpm12020204. J Pers Med. 2022. PMID: 35207692 Free PMC article.
Multicentric evaluation of the variability of digital morphology performances also respect to the reference methods by optical microscopy.
Da Rin G, Seghezzi M, Padoan A, Pajola R, Bengiamo A, Di Fabio AM, Dima F, Fanelli A, Francione S, Germagnoli L, Lorubbio M, Marzoni A, Pipitone S, Rolla R, Bagorria Vaca MDC, Bartolini A, Bonato L, Sciacovelli L, Buoro S; Italian Working Group on Diagnostic Hematology of the Italian Society of Clinical Chemistry and Clinical Molecular Biology (WGDH-SIBioC). Da Rin G, et al. Among authors: germagnoli l. Int J Lab Hematol. 2022 Dec;44(6):1040-1049. doi: 10.1111/ijlh.13943. Epub 2022 Aug 2. Int J Lab Hematol. 2022. PMID: 35916349
17 results